Liu, Hongbo http://orcid.org/0000-0002-0733-8616
Doke, Tomohito http://orcid.org/0000-0003-1641-9351
Guo, Dong
Sheng, Xin http://orcid.org/0000-0002-3620-3577
Ma, Ziyuan http://orcid.org/0000-0002-1512-8993
Park, Joseph http://orcid.org/0000-0002-3313-641X
Vy, Ha My T.
Nadkarni, Girish N. http://orcid.org/0000-0001-6319-4314
Abedini, Amin
Miao, Zhen http://orcid.org/0000-0002-3255-9517
Palmer, Matthew
Voight, Benjamin F. http://orcid.org/0000-0002-6205-9994
Li, Hongzhe
Brown, Christopher D.
Ritchie, Marylyn D. http://orcid.org/0000-0002-1208-1720
Shu, Yan http://orcid.org/0000-0001-8492-1437
Susztak, Katalin http://orcid.org/0000-0002-1005-3726
Funding for this research was provided by:
Foundation for the National Institutes of Health (DK076077, DK105821, DK087635)
Article History
Received: 13 August 2021
Accepted: 9 May 2022
First Online: 16 June 2022
Competing interests
: The laboratory of K.S. receives funding from GSK, Regeneron, Gilead, Merck, Boehringer Ingelheim, Bayer, Novartis Maze, Jnana, Ventus and Novo Nordisk. The funders had no influence on the data analysis. K.S. serves on the scientific advisory board (SAB) of Jnana pharmaceuticals and receives equity. M.D.R. serves on the SAB for Goldfinch Bio and Cipherome. The other authors declare no competing interests.